|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Niederkorn A, Sadoghi B and Komericki P:
Pulsed-dye laser therapy for carcinoma in situ of the penis. Br J
Dermatol. 179:195–196. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lunardi A, Cervelli R, Volterrani D,
Vitali S, Lombardo C, Lorenzoni G, Crocetti L, Bargellini I,
Campani D, Pollina LE, et al: Feasibility of percutaneous
intrahepatic split by microwave ablation (PISA) after portal vein
embolization for hypertrophy of future liver remnant: The
radiological stage-1 ALPPS. Cardiovasc Intervent Radiol.
41:789–798. 2018.PubMed/NCBI
|
|
4
|
Wiksell H, Lofgren L, Schassburger KU,
Grundstrom H, Janicijevic M, Lagerstedt U, Leifland K, Nybom R,
Rotstein S, Saracco A, et al: Feasibility study on the treatment of
small breast carcinoma using percutaneous US-guided preferential
radiofrequency ablation (PRFA). Breast. 19:219–225. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Haar GT and Coussios C: High intensity
focused ultrasound: Physical principles and devices. Int J
Hyperthermia. 23:89–104. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gazis AN, Beuing O, Franke J, Jollenbeck B
and Skalej M: Bipolar radiofrequency ablation of spinal tumors:
Predictability, safety and outcome. Spine J. 14:604–608. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wah TM, Sourbron S, Wilson DJ, Magee D,
Gregory WM, Selby PJ and Buckley DL: Renal cell carcinoma perfusion
before and after radiofrequency ablation measured with dynamic
contrast enhanced MRI: A pilot study. Diagnostics (Basel).
8:E32018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rajyaguru DJ, Borgert AJ, Smith AL, Thomes
RM, Conway PD, Halfdanarson TR, Truty MJ, Kurup AN and Go RS:
Radiofrequency ablation versus stereotactic body radiotherapy for
localized hepatocellular carcinoma in nonsurgically managed
patients: Analysis of the national cancer database. J Clin Oncol.
36:600–608. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee SH, Jin YJ and Lee JW: Survival
benefit of radiofrequency ablation for solitary (3–5 cm)
hepatocellular carcinoma: An analysis for nationwide cancer
registry. Medicine (Baltimore). 96:e84862017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen T, Jin J and Chen S: Clinical
assessment of computed tomography guided radiofrequency ablation in
the treatment of inoperable patients with pulmonary tumors. J
Thoracic Dis. 9:5131–5142. 2017. View Article : Google Scholar
|
|
11
|
Chen J, Zhang C, Li F, Xu L, Zhu H, Wang
S, Liu X, Zha X, Ding Q, Ling L, et al: A meta-analysis of clinical
trials assessing the effect of radiofrequency ablation for breast
cancer. OncoTargets Ther. 9:1759–1766. 2016.
|
|
12
|
Chen K, Zhan MX, Hu BS, Li Y, He X, Fu SR,
Xin YJ and Lu LG: Combination of the neutrophil to lymphocyte ratio
and the platelet to lymphocyte ratio as a useful predictor for
recurrence following radiofrequency ablation of hepatocellular
carcinoma. Oncol Lett. 15:315–323. 2018.PubMed/NCBI
|
|
13
|
Bale R, Richter M, Dunser M, Levy E,
Buchberger W and Schullian P: Stereotactic radiofrequency ablation
for breast cancer liver metastases. J Vasc Interv Radiol.
29:262–267. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mauri G, Sconfienza LM, Pescatori LC,
Fedeli MP, Ali M, Di Leo G and Sardanelli F: Technical success,
technique efficacy and complications of minimally-invasive
imaging-guided percutaneous ablation procedures of breast cancer: A
systematic review and meta-analysis. Eur Radiol. 27:3199–3210.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nguyen T, Hattery E and Khatri VP:
Radiofrequency ablation and breast cancer: A review. Gland Surg.
3:128–135. 2014.PubMed/NCBI
|
|
16
|
Shah DR, Green S, Elliot A, McGahan JP and
Khatri VP: Current oncologic applications of radiofrequency
ablation therapies. World J Gastrointest Oncol. 5:71–80. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oura S, Tamaki T, Hirai I, Yoshimasu T,
Ohta F, Nakamura R and Okamura Y: Radiofrequency ablation therapy
in patients with breast cancers two centimeters or less in size.
Breast Cancer. 14:48–54. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Earashi M, Noguchi M, Motoyoshi A and
Fujii H: Radiofrequency ablation therapy for small breast cancer
followed by immediate surgical resection or delayed mammotome
excision. Breast Cancer. 14:39–47. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamamoto N, Fujimoto H, Nakamura R, Arai
M, Yoshii A, Kaji S and Itami M: Pilot study of radiofrequency
ablation therapy without surgical excision for T1 breast cancer:
Evaluation with MRI and vacuum-assisted core needle biopsy and
safety management. Breast Cancer. 18:3–9. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hua YQ, Wang P, Zhu XY, Shen YH, Wang K,
Shi WD, Lin JH, Meng ZQ, Chen Z and Chen H: Radiofrequency ablation
for hepatic oligometastatic pancreatic cancer: An analysis of
safety and efficacy. Pancreatology. 17:967–973. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li P, Xiao-Yin T, Cui D, Chi JC, Wang Z,
Wang T, Qi XX and Zhai B: Evaluation of the safety and efficacy of
percutaneous radiofrequency ablation for treating multiple breast
fibroadenoma. J Cancer Res Ther. 12 (Suppl):C138–C142. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang H, Liu B, Long H, Zhang F, Wang S and
Li F: Clinical study of radiofrequency ablation combined with TACE
in the treatment of breast cancer with liver metastasis. Oncol
Lett. 14:2699–2702. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chiu HY, Leu JD, Chang CY, Lee YJ and Chen
WR: Combination of radiofrequency ablation and glycated chitosan as
treatment on a syngeneic breast tumor model. Anticancer Res.
37:2965–2974. 2017.PubMed/NCBI
|
